News

Experimental drug blocks protein that links low blood sugar to diabetic vision loss
In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined ...
EurekAlert!6d
Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; experimental drug may help treat condition
Diabetic retinopathy, a severe complication of both ... Some diabetic mice received an injection of 32-134D prior to induced episodes of low blood sugar, and researchers observed lower HIF levels ...
Healio4d
VIDEO: OTX-TKI reduces intraretinal fluid over 1 year with single injection
In this Healio Video Perspective from the ARVO meeting, Justis P. Ehlers, MD, shares results from the phase 1 HELIOS study ...
GEN - Genetic Engineering and Biotechnology News4d
Vision Loss in Diabetic Mice Promoted by Hypoglycemia, Treated with HIF Inhibitors
Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...
Ophthalmology Times11d
Regeneron to highlight real-world efficacy of aflibercept 8 mg (Eylea HD) in wAMD, DME, and DR
The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...
GlobalData on MSN9d
FDA awards RMAT status to 4DMT diabetic macular oedema therapy
It is intended to alleviate the burden of frequent injections for individuals suffering ... invented using 4DMT’s Therapeutic ...
Medical Dialogues3d
Foselutoclax Promising for Diabetic Macular Edema Unresponsive to Anti-VEGF Therapy: Study
Researchers have discovered in an ongoing phase IIb trial that a single intravitreal injection of UBX1325 (foselutoclax), a ...